State Street Corp Sells 740,645 Shares of Enhabit, Inc. (NYSE:EHAB)

State Street Corp trimmed its holdings in shares of Enhabit, Inc. (NYSE:EHABFree Report) by 38.9% during the third quarter, Holdings Channel.com reports. The institutional investor owned 1,161,697 shares of the company’s stock after selling 740,645 shares during the quarter. State Street Corp’s holdings in Enhabit were worth $9,177,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. FMR LLC raised its holdings in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after buying an additional 1,967 shares during the last quarter. Quarry LP boosted its holdings in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares during the last quarter. Gladius Capital Management LP grew its stake in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock worth $49,000 after acquiring an additional 2,747 shares in the last quarter. Stoneridge Investment Partners LLC purchased a new stake in shares of Enhabit in the third quarter valued at about $81,000. Finally, Canada Pension Plan Investment Board bought a new position in shares of Enhabit during the second quarter valued at about $93,000.

Insider Transactions at Enhabit

In other Enhabit news, Director Stuart M. Mcguigan acquired 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the purchase, the director now owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeffrey Bolton bought 4,000 shares of Enhabit stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the transaction, the director now owns 98,144 shares of the company’s stock, valued at $852,871.36. This represents a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is owned by corporate insiders.

Enhabit Stock Performance

NYSE EHAB opened at $7.73 on Friday. The company has a market capitalization of $388.70 million, a PE ratio of -3.33 and a beta of 1.89. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.74. The company has a 50-day simple moving average of $7.67 and a 200 day simple moving average of $8.24.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter in the previous year, the business earned $0.03 EPS. On average, research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Analyst Upgrades and Downgrades

EHAB has been the subject of a number of recent analyst reports. Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and upped their target price for the company from $8.25 to $9.50 in a report on Monday, December 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.75.

Read Our Latest Analysis on Enhabit

About Enhabit

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.